Li W - Search Results

1

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.

Li W, Qiu T, Zhi W, Shi S, Zou S, Ling Y, Shan L, Ying J, Lu N. Li W, et al. BMC Cancer. 2015 May 1;15:340. doi: 10.1186/s12885-015-1345-3. BMC Cancer. 2015. PMID: 25929517 Free PMC article.

2

The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.

Zou SM, Li WH, Wang WM, Li WB, Shi SS, Ying JM, Lyu N. Zou SM, et al. J Cancer Res Clin Oncol. 2018 Nov;144(11):2149-2159. doi: 10.1007/s00432-018-2742-1. Epub 2018 Aug 31. J Cancer Res Clin Oncol. 2018. PMID: 30171333

3

Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay.

Qiu T, Lu H, Guo L, Huang W, Ling Y, Shan L, Li W, Ying J, Lv N. Qiu T, et al. Among authors: li w. Sci Rep. 2015 Mar 18;5:9211. doi: 10.1038/srep09211. Sci Rep. 2015. PMID: 25784606 Free PMC article.

4

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.

Li W, Zhi W, Zou S, Qiu T, Ling Y, Shan L, Shi S, Ying J. Li W, et al. PLoS One. 2015 Jun 4;10(6):e0128202. doi: 10.1371/journal.pone.0128202. eCollection 2015. PLoS One. 2015. PMID: 26042813 Free PMC article.

5

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma.

Shan L, Qiu T, Ling Y, Guo L, Zheng B, Wang B, Li W, Li L, Ying J. Shan L, et al. Among authors: li w, li l. PLoS One. 2015 Jun 23;10(6):e0130447. doi: 10.1371/journal.pone.0130447. eCollection 2015. PLoS One. 2015. PMID: 26102513 Free PMC article.

6

Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations.

Li W, Qiu T, Ling Y, Guo L, Li L, Ying J. Li W, et al. Among authors: li l. Oncotarget. 2015 Nov 24;6(37):39607-13. doi: 10.18632/oncotarget.5551. Oncotarget. 2015. PMID: 26530529 Free PMC article.

7

Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients.

Li W, Song P, Guo L, Liu X, Guo C, Ying J, Gao S. Li W, et al. Thorac Cancer. 2019 Feb;10(2):175-182. doi: 10.1111/1759-7714.12929. Epub 2018 Dec 11. Thorac Cancer. 2019. PMID: 30536734 Free PMC article. Clinical Trial.

8

Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer.

Song P, Zhang F, Li Y, Yang G, Li W, Ying J, Gao S. Song P, et al. Among authors: li y, li w. Cancer Med. 2019 Apr;8(4):1551-1557. doi: 10.1002/cam4.2043. Epub 2019 Mar 7. Cancer Med. 2019. PMID: 30843662 Free PMC article.

9

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.

Shan L, Wang Z, Guo L, Sun H, Qiu T, Ling Y, Li W, Li L, Liu X, Zheng B, Lu N, Ying J. Shan L, et al. Among authors: li w, li l. Lung Cancer. 2015 Sep;89(3):337-42. doi: 10.1016/j.lungcan.2015.06.008. Epub 2015 Jun 19. Lung Cancer. 2015. PMID: 26141217

10

Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.

Li W, Zhang Z, Guo L, Qiu T, Ling Y, Cao J, Guo H, Zhao H, Li L, Ying J. Li W, et al. Among authors: li l. Oncotarget. 2016 Feb 16;7(7):8332-40. doi: 10.18632/oncotarget.6671. Oncotarget. 2016. PMID: 26789109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,347 results

Search Page

Filters